These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8502705)

  • 41. Hepatitis delta virus heterogeneity: a study by immunofluorescence.
    Negro F; Pacchioni D; Bussolati G; Bonino F
    J Hepatol; 1991; 13 Suppl 4():S125-9. PubMed ID: 1822506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of chronic type B hepatitis in southern Italy: effect of HBV replication and of HDV infection.
    Craxì A; Di Marco V; Magrin S; Scalisi I; Vassallo R; Vinci M; Genova G; D'Amico G; Maisano S; Politi F
    Prog Clin Biol Res; 1987; 234():153-65. PubMed ID: 3628374
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Course of hepatitis delta virus infection in auxiliary liver grafts in patients with delta virus cirrhosis.
    ten Kate FJ; Schalm SW
    Prog Clin Biol Res; 1991; 364():429-37. PubMed ID: 2020719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection.
    Jardi R; Buti M; Cotrina M; Rodriguez F; Allende H; Esteban R; Guardia J
    Hepatology; 1995 Jan; 21(1):25-9. PubMed ID: 7528710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel targets of anti-hepatitis delta virus therapy.
    Glenn JS; White JM
    Prog Clin Biol Res; 1993; 382():53-60. PubMed ID: 8502717
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical significance of the hepatitis Delta virus and its incidence in virus B positive chronic liver diseases].
    Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 1992 Jul; 133 Suppl 1():39-44. PubMed ID: 1630804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
    Rizzetto M; Rosina F; Saracco G; Bellando PC; Actis GC; Bonino F; Smedile A; Trinchero P; Sansalvadore F; Pintus C
    J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant hepatitis delta antigen from E. coli promotes hepatitis delta virus RNA replication only from the genomic strand but not the antigenomic strand.
    Sheu GT; Lai MM
    Virology; 2000 Dec; 278(2):578-86. PubMed ID: 11118380
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatitis due to HDV infections].
    Walewska-Zielecka B; Nazarewicz-de Mezer T; Nowosławski A
    Patol Pol; 1990; 41(4):157-63. PubMed ID: 2152516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emergence of the long form of hepatitis delta virus antigen in transfected cells after intrahepatic transfection and during natural infection.
    Yang A; Karayiannis P; Cheng D; Hadziyannis SJ; Thomas H; Monjardino J
    Prog Clin Biol Res; 1993; 382():145-8. PubMed ID: 8502672
    [No Abstract]   [Full Text] [Related]  

  • 54. Pathobiology of hepatitis delta virus infection at the cell level.
    Negro F; Pacchioni D; Bussolati G; Ardeleanu C; Verme G; Rizzetto M; Bonino F
    Prog Clin Biol Res; 1993; 382():155-60. PubMed ID: 8502674
    [No Abstract]   [Full Text] [Related]  

  • 55. Immuno-light and electron microscopic features of chronic hepatitis D.
    Kojima T; Callea F; Desmyter J; Sakurai I; Desmet VJ
    Liver; 1990 Feb; 10(1):17-27. PubMed ID: 2308477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An enzyme immunoassay for detection of IgA class antibodies against hepatitis delta virus.
    Chaggar K; McFarlane IG; Smith HM; Alexander GJ; Williams R
    J Virol Methods; 1991 May; 32(2-3):193-9. PubMed ID: 1874915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interferon therapy in chronic viral hepatitis].
    Welland O
    Nord Med; 1992; 107(3):72-3, 75. PubMed ID: 1549455
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chronic hepatitis delta--the course and approaches to therapy].
    Blokhina NP; Ketiladze ES; Kelli EI; Viazov SO
    Klin Med (Mosk); 1991 Mar; 69(3):85-8. PubMed ID: 2067348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A histological study of hepatitis delta virus liver disease.
    Verme G; Amoroso P; Lettieri G; Pierri P; David E; Sessa F; Rizzi R; Bonino F; Recchia S; Rizzetto M
    Hepatology; 1986; 6(6):1303-7. PubMed ID: 3793008
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of alpha 2b interferon.
    Dény P; Fattovich G; Le Gal F; Giustina G; Lecot C; Morsica G; Poinsot H; Alberti A; Bréchot C
    Res Virol; 1994; 145(5):287-95. PubMed ID: 7839006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.